Compounding Pharmacy Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 14.31 Billion |
| Market Size (2029) | USD 18.86 Billion |
| CAGR (2024 - 2029) | 5.68 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Compounding Pharmacy Market Analysis
The Compounding Pharmacy Market size is estimated at USD 14.31 billion in 2024, and is expected to reach USD 18.86 billion by 2029, growing at a CAGR of 5.68% during the forecast period (2024-2029).
The key factors responsible for the market's growth include increasing demand for personalized medicine, drug shortage, and the rising geriatric population.
The growing geriatric population is one of the leading factors for market growth as they are more prone to various diseases that ultimately require different types of medicines. For instance, according to the report from the United Nations published in January 2023, the number of people aged over 65 or older is expected to double in the next three decades; it is expected to reach around 1.6 billion by 2050. The senior population is more prone to chronic and complex diseases, such as cardiovascular diseases, cancer, and others that need personalized treatment. Hence, the demand for compounding pharmacies is expected to increase to treat complex diseases in the geriatric population, driving market growth over the forecast period.
The drug shortage in several countries is likely to accelerate the compounding pharmacy market's growth. For instance, according to the Pharmaceutical Group of the European Union Medicine Shortage Report 2023, there was an increase of 36% in medicine shortages in 2023 compared to 2022 in Europe. As per the same report, medicine shortages in patients and pharmacies across Europe accentuated and significantly impacted the market, ultimately creating opportunities for compounding pharmacies and propelling the market’s growth during the forecast period.
Hence, owing to the increase in the geriatric population and rising issues associated with medicine shortages, the market is expected to witness notable growth over the forecast period. However, the need for skilled compounding pharmacists is expected to hinder market growth in the coming years.
Compounding Pharmacy Market Trends
The Pain Management Segment is Expected to Dominate the Market During the Forecast Period
The pain management segment is expected to account for the largest share of the market owing to the large patient base suffering from chronic pain from various diseases. Increasing accidental cases, the high burden of cancer, and chronic pain cases are key factors responsible for the growth of the pain management market. For instance, according to the May 2023 update by the National Institute of Health, new cases of chronic pain occurred more often among US adults than new cases of several other common conditions, including diabetes, depression, and high blood pressure. Furthermore, almost two-thirds of the chronic disease population suffered from pain. Compounding pharmacies provide drugs for effective pain management tailored for specific patients. Thus, the pain management segment is expected to contribute to the market's growth during the forecast period.
Non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, topical analgesics, and opioids are the major classes of drugs that doctors prescribe for chronic pain management. These drugs are available by prescription to relieve fever and pain. For instance, as per the article published in November 2023 in the International Journal of Pharmaceutical Compounding Inc., low doses of naltrexone were found to be beneficial among patients who had pain associated with the diagnosis of idiopathic hypereosinophilic syndrome. Thus, owing to such personalized approaches, the segment is expected to witness notable growth over the forecast period.
Side effects associated with these medications include stomach irritation, unpleasant side effects, and unwanted flavor/route of administration. Compounding pharmacies provide alternate methods to ease consumption and cope with the side effects. Such an advantage of compounding pharmacies is expected to accelerate market growth.
North America is Expected to Witness Significant Growth Over the Forecast Period
The compounding pharmacy market in North America is expected to hold a significant market share during the forecast period. The presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs are key factors for market growth. Annual conferences in the region discussing updates and advancements in the compounding of drugs are expected to drive market growth over the forecast period. For instance, in November 2023, the US Food and Drug Administration (FDA) virtually conducted its 12th intergovernmental working meeting on drug compounding with state government officials, including officials from state regulators, representatives from the National Association of Boards of Pharmacy (NABP), and other representatives from FDA.
Several organizations are interested in the compounding pharmacy market across the United States. For instance, in July 2022, Fagron, the global player in pharmaceutical compounding, acquired a 503B outsourcing facility from Fresenius Kabi in Boston. With this acquisition, Fagron expanded its US sterile compounding footprint. Similarly, in June 2022, Osceola Capital, a private equity firm, opened its eighth addition to the Revelation Pharma Corporation platform by purchasing Wedgewood Pharmacy’s Human-Health Book of Business. Wedgewood Pharmacy operates compounding pharmacies that offer sterile and non-sterile compounded medications for animal patients in 50 states.
Hence, owing to the developments in compounding pharmacies and the rise in strategic activities by the key players, the market is expected to witness strong growth in the region.
Compounding Pharmacy Industry Overview
The compounding pharmacy market is semi-consolidated. The key market players are continuously involved in various strategic activities to increase their footprints across geographies. B. Braun SE, Athenex Pharma Solutions, Fresenius Kabi, Clinigen Group PLC, Dougherty's Pharmacy Inc., Mcguff Compounding Pharmacy Services, Pencol Compounding Pharmacy, ITC Compounding Pharmacy, and Valor Compounding Pharmacy are some of the key players in the market.
Compounding Pharmacy Market Leaders
-
Fresenius Kabi
-
Wedgewood Pharmacy
-
Clinigen Group PLC
-
Fagron NV
-
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
Compounding Pharmacy Market News
- February 2024: Empower Pharma agreed to purchase a facility in East Windsor, New Jersey, from Eugia US Manufacturing LLC (a wholly-owned subsidiary of Aurobindo Pharma Ltd) and enter into a contract manufacturing relationship for expanding their personalized compounded medicine.
- September 2023: LO3 Capital, a private investment firm, offered a senior subordinated debt investment to support Empower Pharmacy (Empower) with growth capital. The investment was intended to help in expanding patient access to quality, affordable, compounded medication.
Compounding Pharmacy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Demand of Personalized Medicine
- 4.2.2 Shortage of Drugs
- 4.2.3 Rising Geriatric Population
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Compounding Pharmacists
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value – USD)
-
5.1 By Therapeutic Area
- 5.1.1 Pain Management
- 5.1.2 Hormone Replacement
- 5.1.3 Dermal Disorders
- 5.1.4 Nutritional Supplements
- 5.1.5 Other Therapeutic Areas
-
5.2 By Route of Administration
- 5.2.1 Oral
- 5.2.2 Topical
- 5.2.3 Parenteral
- 5.2.4 Other Route of Administrations
-
5.3 By End-User
- 5.3.1 Humans
- 5.3.2 Veterinary
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 B. Braun SE
- 6.1.2 Fagron NV
- 6.1.3 Fresenius Kabi
- 6.1.4 Wedgewood Pharmacy
- 6.1.5 Clinigen Group PLC
- 6.1.6 Dougherty's Pharmacy Inc.
- 6.1.7 Lorraine's Pharmacy
- 6.1.8 Rx3 Compounding Pharmacy
- 6.1.9 Institutional Pharmacy Solutions
- 6.1.10 Mcguff compounding pharmacy services
- 6.1.11 Pencol Compounding Pharmacy
- 6.1.12 ITC Compounding Pharmacy
- 6.1.13 Valor Compounding Pharmacy Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityCompounding Pharmacy Industry Segmentation
As per the scope of this report, a compounding pharmacy is a formulation of personalized or custom pharmaceutical products that are unique to the patient's needs and generally not available commercially.
The compounding pharmacy market is segmented by therapeutic area, route of administration, end user, and geography. By therapeutic area, the market is segmented into pain management, hormone replacement, dermal disorders, nutritional supplements, and other therapeutic areas. By route of administration, the market is segmented into oral, topical, parenteral, and other routes of administration. By end user, the market is segmented into humans and veterinary. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for all the above segments.
| By Therapeutic Area | Pain Management | |
| Hormone Replacement | ||
| Dermal Disorders | ||
| Nutritional Supplements | ||
| Other Therapeutic Areas | ||
| By Route of Administration | Oral | |
| Topical | ||
| Parenteral | ||
| Other Route of Administrations | ||
| By End-User | Humans | |
| Veterinary | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Compounding Pharmacy Market Research FAQs
How big is the Compounding Pharmacy Market?
The Compounding Pharmacy Market size is expected to reach USD 14.31 billion in 2024 and grow at a CAGR of 5.68% to reach USD 18.86 billion by 2029.
What is the current Compounding Pharmacy Market size?
In 2024, the Compounding Pharmacy Market size is expected to reach USD 14.31 billion.
Who are the key players in Compounding Pharmacy Market?
Fresenius Kabi, Wedgewood Pharmacy, Clinigen Group PLC, Fagron NV and B. Braun SE are the major companies operating in the Compounding Pharmacy Market.
Which is the fastest growing region in Compounding Pharmacy Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Compounding Pharmacy Market?
In 2024, the North America accounts for the largest market share in Compounding Pharmacy Market.
What years does this Compounding Pharmacy Market cover, and what was the market size in 2023?
In 2023, the Compounding Pharmacy Market size was estimated at USD 13.50 billion. The report covers the Compounding Pharmacy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Compounding Pharmacy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Compounding Pharmacy Industry Report
The Compounding Pharmacy Market Report provides a comprehensive industry analysis, including market size, industry data, and industry trends. The report segments the market by therapeutic area, route of administration, end user, and geography, offering valuable insights into market segmentation and market value.
The industry report highlights key market leaders and provides a detailed market overview, covering various aspects such as market growth, market forecast, and market outlook. The report also includes a market review and market predictions, helping stakeholders understand the industry's future trajectory.
The analysis includes industry information, industry outlook, and industry statistics, presenting a thorough understanding of the market dynamics. Industry research and industry sales data are also covered, providing a holistic view of the market landscape.
Additionally, the report offers a report example and a report PDF, allowing readers to access detailed industry reports and market data. Research companies can benefit from the insights provided, enabling them to make informed decisions based on the industry trends and market growth.
Overall, the Compounding Pharmacy Market Report serves as a valuable resource for understanding the market's current state and future prospects, supported by comprehensive industry research and detailed market analysis.
